Discovery of Potential Inhibitors of Mycobacterium tuberculosis EthR Using Structure and Ligand Based in silico Approaches
نویسندگان
چکیده
Abstract: Aim and Background: Mycobacterium tuberculosis (TB) remains the leading cause of human death posing one most serious threats to public health around world. New strategies need be developed combat growing danger by multidrug resistance. The present study aims screen three different compounds inhibiting binding pocket Regulatory Repressor Protein EthR tuberculosis. In this we performed pharmacophore modeling based virtual screening identify potential inhibitors against Based on energy hydrogen bond interactions were selected as inhibitors. Materials Methods: Structure protein (PDB ID: 5NZ0) was retrieved from pdb databank. Further, ligands ZINC database (ZINC223412753, ZINC030691754, ZINC170602403). Next, Computational screening, Docking studies Molecular dynamic simulations validate stability complexes. Results: molecular docking showed that all interact with Mycobacteriam. dynamics simulation ligand ZINC223412753 form comparatively more stable complex EthR. Results could a inhibitor Conclusion: These can serve starting point in rational design selective potent Keywords: tuberculosis, Pharmacophore, Docking, Virtual Screening, Dynamic Simulations, Inhibitors.
منابع مشابه
Discovery of new human DHODH inhibitors using a Structure-Based and a Ligand-Based Pharmacophore approaches
Dihydroorotate Dehydrogenase (DHODH) is a mitochondrial protein involved in de novo pyrimidine biosynthesis, catalyzing the ubiquinone-mediated oxidation of dihydroorotate (DHO) to orotate. DHODH is considered to be a validated target for the development of immune-modulating agents. In this work two different approaches were used to create a pharmacophore model, which was subsequently used in a...
متن کاملPotential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches.
Renin, an enzyme by cleaving angiotensinogen to angiotensin-I, controls the first and rate-limiting step of renin-angiotensin system that is associated with blood pressure. Thus Ligand and structure-based pharmacophore models were developed in this study to identify new potential leads inhibiting this rate-limiting enzyme as an efficient way to treat blood pressure. X-ray predicted binding mode...
متن کاملFragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
Small-molecule inhibitors of the mycobacterial transcriptional repressor EthR have previously been shown to act as boosters of the second-line antituberculosis drug ethionamide. Fragment-based drug discovery approaches have been used in the past to make highly potent EthR inhibitors with ethionamide boosting activity both in vitro and ex vivo. Herein, we report the development of fragment-sized...
متن کاملNew approaches to structure-based discovery of dengue protease inhibitors.
Dengue virus (DENV), a member of the family Flaviviridae, presents a tremendous threat to global health since an estimated 2.5 billion people worldwide are at risk for epidemic transmission. DENV infections are primarily restricted to sub-tropical and tropical regions; however, there is concern that the virus will spread into new regions including the United States. There are no approved antivi...
متن کاملIn silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA)
Computer-aided drug discovery and development approaches such as virtual screening, molecular docking, and in silico drug property calculations have been utilized in this effort to discover new lead compounds against tuberculosis. The enzyme 7,8-diaminopelargonic acid aminotransferase (BioA) in Mycobacterium tuberculosis (Mtb), primarily involved in the lipid biosynthesis pathway, was chosen as...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Pharmaceutical Education and Research
سال: 2022
ISSN: ['0019-5464']
DOI: https://doi.org/10.5530/ijper.56.4.193